Published: Jun, 2017
The global market for pharmacovigilance demonstrates a highly fragmented and competitive landscape, thanks to the presence of a large pool of established as well as startups, finds a new study by Transparency Market Research (TMR). Prompted by its exponential growth, a number of BPOs and CROs from across the world are looking to foray into this market, which is likely to increase the competition in the years to come. The leading companies, such as Accenture Plc, Cognizant Technology Solutions, Bristol-Myers Squibb, and Covance Inc., are likely to focus on technological advancements in their offerings over the next few years, states the report.
As per the research report, the global pharmacovigilance market, which was US$2.4 bn in 2013, is anticipated to rise at a CAGR of 14.20% during the period for 2014 to 2020 and reach a value of US$6.1 bn by the end of the forecast period. Spontaneous reporting has been the most preferred method of pharmacovigilance across the world and is anticipated to remain so over the next few years, note the study.
Demand for Contract Outsourcing Services to Remain Strong
In-house and contract outsourcing services have been considered as the most preferred pharmacovigilance services across the world in this report. The demand for contract outsourcing services is much higher than the in-house ones and the scenario is likely to remain so over the forthcoming years, thanks to the rising need of pharma companies to shift their focus from non-core to their core business activities by outsourcing pharmacovigilance services.
In terms of the geography, the report classifies this market into North America, Asia Pacific, Europe, and the Rest of the World. North America, among these, has been leading the global market. Researchers anticipate this regional market to remain on the top over the forecast period, thanks to the escalating mortality rate, fueled by ADRs, and the rising concerns of patients pertaining to the safety and the efficiency of pharmaceutical products, states the report.
Rising Number of Government Pharmacovigilance Centers to Boost Market’s Growth
According to an analyst at TMR, the growing awareness pertaining to the public health and the increasing demand for medical interventions and safe practices of medicines are boosting the market for pharmacovigilance substantially across the world. “The rising number of government pharmacovigilance centers, globally, is playing a decisive role in increasing the public awareness level regarding drug safety and, consequently, influencing this market,” he adds.
The market, however, is facing several issues and challenges in developing a technologically advanced healthcare system. The growth of this market may also be hindered by the dearth of skilled professionals and the high risk associated with the data security in the near future, reports the study.
The study presented here is based on a report by Transparency Market Research (TMR), titled “Pharmacovigilance Market (Phases of Drug Development - Preclinical Studies, Phase I, Phase II, Phase III, and Phase IV or Post Marketing Surveillance; Type of Method - Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, and EHR Mining; Type of Service - In-house and Contract Outsourcing - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020.”
The global market for pharmacovigilance is segmented into:
By Phases of Drug Development
- Preclinical Studies
- Phase I
- Phase II
- Phase III
- Phase IV or Post Marketing Surveillance
By Types of Methods
- Spontaneous Reporting
- Intensified ADR Reporting
- Targeted Spontaneous Reporting
- Cohort Event Monitoring
- EHR Mining
By Type of Service
- Contract Outsourcing
- North America
- Asia Pacific
- Rest of the World (RoW)
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
USA - Canada Toll Free: 866-552-3453